Prevention Trials: Their Place in How We Understand the Value of Prevention Strategies

被引:18
|
作者
Colditz, Graham A. [1 ]
Taylor, Philip R. [2 ]
机构
[1] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA
[2] NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA
来源
ANNUAL REVIEW OF PUBLIC HEALTH, VOL 31 | 2010年 / 31卷
关键词
durability; adherence; bias; behavior modification; drugs; intention-to-treat; HEALTHY POSTMENOPAUSAL WOMEN; SURGICAL ADJUVANT BREAST; ESTROGEN PLUS PROGESTIN; DESIGN AFFECTS OUTCOMES; CANCER PREVENTION; PUBLIC-HEALTH; COLORECTAL ADENOMAS; ADOLESCENT DIET; BETA-CAROTENE; LUNG-CANCER;
D O I
10.1146/annurev.publhealth.121208.131051
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Several key factors bear on the interpretation of prevention trials and observational studies that inform prevention strategies. These factors include the underlying disease process and aspects of the intervention: sustainability of behavior change, the time course of the intervention within the disease process, dose and duration of exposure needed to effect risk reduction, durability of the impact of intervention, and methodological problems in implementing and interpreting randomized trials and observational studies to evaluate prevention strategies. The question asked through an intent-to-treat analysis of a randomized controlled trial (RCT) differs from that in the observational setting. Furthermore, the long duration necessary to conduct prevention trials and the resulting lack of adherence to therapy can bias results toward the null. A broader range of approaches to evaluate prevention interventions and programs with improved knowledge synthesis and translation to public health practice will speed our progress toward achieving public health and prevention of chronic diseases.
引用
收藏
页码:105 / 120
页数:16
相关论文
共 50 条
  • [21] How Biomedical HIV Prevention Trials Incorporate Behavioral and Social Sciences Research: A Typology of Approaches
    Corneli, Amy
    Meagher, Karen
    Henderson, Gail
    Peay, Holly
    Rennie, Stuart
    AIDS AND BEHAVIOR, 2019, 23 (08) : 2146 - 2154
  • [22] Why the prevention strategies are in low priority?
    Xuanqian Xie Department of Pablic Health
    Journal of Nanjing Medical University, 2006, (02) : 70 - 73
  • [23] Wood decomposition: Mechanisms and prevention strategies
    Thybring, Emil E. E.
    Thygesen, Lisbeth G. G.
    Alfredsen, Gry
    Fredriksson, Maria
    FRONTIERS IN PLANT SCIENCE, 2022, 13
  • [24] STRATEGIES FOR THE PREVENTION OF MESOTHELIOMA IN MEXTAG MICE
    Robinson, Cleo
    Woo, Samantha
    Walsh, Amy
    Alfonso, Helman
    Nowak, Anna K.
    Lake, Richard
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1069 - S1069
  • [25] Obesity, metabolic and bariatric surgery, and cancer prevention: what do we need to learn and how do we get there?
    Sauter, Edward R.
    SURGERY FOR OBESITY AND RELATED DISEASES, 2023, 19 (07) : 781 - 787
  • [26] The Prevention and Treatment of Missing Data in Clinical Trials
    Little, Roderick J.
    D'Agostino, Ralph
    Cohen, Michael L.
    Dickersin, Kay
    Emerson, Scott S.
    Farrar, John T.
    Frangakis, Constantine
    Hogan, Joseph W.
    Molenberghs, Geert
    Murphy, Susan A.
    Neaton, James D.
    Rotnitzky, Andrea
    Scharfstein, Daniel
    Shih, Weichung J.
    Siegel, Jay P.
    Stern, Hal
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (14) : 1355 - 1360
  • [27] Can psychoanalysis help us to understand the causes and prevention of violence?
    Gilligan, James
    PSYCHOANALYTIC PSYCHOTHERAPY, 2016, 30 (02) : 125 - 137
  • [28] Adherence Support Approaches in Biomedical HIV Prevention Trials: Experiences, Insights and Future Directions from Four Multisite Prevention Trials
    K. Rivet Amico
    Leila E. Mansoor
    Amy Corneli
    Kristine Torjesen
    Ariane van der Straten
    AIDS and Behavior, 2013, 17 : 2143 - 2155
  • [29] Phase II Cancer Prevention Clinical Trials
    Szabo, Eva
    SEMINARS IN ONCOLOGY, 2010, 37 (04) : 359 - 366
  • [30] Adherence Support Approaches in Biomedical HIV Prevention Trials: Experiences, Insights and Future Directions from Four Multisite Prevention Trials
    Amico, K. Rivet
    Mansoor, Leila E.
    Corneli, Amy
    Torjesen, Kristine
    van der Straten, Ariane
    AIDS AND BEHAVIOR, 2013, 17 (06) : 2143 - 2155